Table 1 Characteristics of PML patients
| Â | HIV | Risk factor | CSF composition | CD4/CD8 ratio (blood) | CSF JCPyV-DNA IU/mL | NCCR organization |
|---|---|---|---|---|---|---|
Case 1 | negative | natalizumab | glucose: 54 mg/dl proteins: 569 mg/L cell count: 5 cells/μl | 0.45 | 1.62 × 106 | A–B*–C–E–F |
Case 2 | negative | dimethyl fumarate | glucose: 56 mg/dl proteins: 35 mg/L cell count: 2 cells/μl | 5.36 | 4.9 × 105 | A–B–C–(D)–E–F |
Case 3 | positive | HIV infection | glucose: 76 mg/dl proteins: 413 mg/L cell count: 2 cells/μl | 0.10 | 8.97 × 105 | A-B-(C)-(E)-(F)-(B)-(C)-(E)-F* |
Case 4 | positive | HIV infection | glucose: 43 mg/dl proteins: 46 mg/L cell count: 2 cells/μl | 0.11 | 2.34 × 106 | A–C*–E*–F* |